NRI think that the NR was great BUT... they need to decide what cancer they are going to take into trials... who cares about these results if they are going ahead with bladder cancer. The market wants them to take the first step forward. If that same release also stated that because of those results they would be concentrating on Ovarian Cancer for their trials I believe we would have had a stellar day.